{"id":"W4312018944","doi":"10.1016/j.annonc.2022.12.007","title":"Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial","year":2022,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University of British Columbia","funders":"Merck Sharp and Dohme","keywords":"Medicine; Pembrolizumab; Internal medicine; Oncology; Chemotherapy; Docetaxel; Population; Capecitabine; Gemcitabine; Cancer; Surgery; Immunotherapy; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00200843,0.001774986,0.002283677,0.0003407623,0.0004376822,0.001270724,0.001066546,0.001677128,0.008591035],"category_scores_gemma":[0.001704744,0.0006602974,0.001327173,0.0004708873,0.0008040656,0.001412438,0.000454388,0.002287507,0.001166914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007175175,"about_ca_system_score_gemma":0.001067914,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006203138,"about_ca_topic_score_gemma":0.001569927,"domain_scores_codex":[0.9994948,0.000252063,0.00003483102,0.00011243,0.00004458258,0.00006135298],"domain_scores_gemma":[0.9993254,0.0001399392,0.0001589051,0.0000599301,0.0000533659,0.0002624143],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9462169,0.01781246,0.0005706139,0.00171332,0.0009003901,0.00008243979,0.0000748215,0.00044552,0.006792092,0.0002111058,0.00224077,0.02293971],"study_design_scores_gemma":[0.9379178,0.05945636,0.0009108512,0.00004296787,0.0002737187,0.00004614653,0.00001650694,0.0002457542,0.0003606807,0.00007985885,0.0006390649,0.00001032388],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9766222,0.006812292,0.0006876753,0.0008365995,0.0005830295,0.008250873,0.002188436,0.0002341445,0.003784769],"genre_scores_gemma":[0.9782652,0.004169497,0.001854631,0.001721448,0.0004800924,0.007375584,0.001889807,0.00003219951,0.004211691],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008591035,"threshold_uncertainty_score":0.02873987,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2366118768115211,"score_gpt":0.5025671330450882,"score_spread":0.2659552562335671,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}